Baird raised the firm’s price target on Emerson (EMR) to $140 from $136 and keeps a Neutral rating on the shares. The firm said the business seems to be hitting stride at just the right time.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMR: